Cited 0 time in
Optimal surgical extent of lateral and central neck dissection for papillary thyroid carcinoma located in one lobe with clinical lateral lymph node metastasis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Keum, Hyo Sub | - |
| dc.contributor.author | Ji, Yong Bae | - |
| dc.contributor.author | Kim, Jong Min | - |
| dc.contributor.author | Jeong, Jin Hyeok | - |
| dc.contributor.author | Choi, Woong Hwan | - |
| dc.contributor.author | Ahn, You Hern | - |
| dc.contributor.author | Tae, Kyung | - |
| dc.date.accessioned | 2022-07-16T13:41:28Z | - |
| dc.date.available | 2022-07-16T13:41:28Z | - |
| dc.date.issued | 2012-10 | - |
| dc.identifier.issn | 1477-7819 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/164619 | - |
| dc.description.abstract | Background: The indications and extent of cervical lymph node dissection in papillary thyroid carcinoma (PTC) are still being debated. The aim of this study was to analyze the patterns of cervical lymph node metastasis in the lateral and central compartment and related factors and suggest the optimal extent of lateral and central neck dissection for PTC patients with clinical lateral lymph node metastasis. Methods: We retrospectively analyzed 72 patients with unilateral PTC who underwent therapeutic lateral neck dissections with concomitant total thyroidectomy and central neck dissection between January 2001 and December 2009. Results: The 72 patients underwent 79 sides of therapeutic lateral neck dissection. The most frequent metastatic level in the ipsilateral lateral compartment was level IV (75.0%), followed by level III (69.4%), level II (56.9%) and level V (20.8%). Multiple level metastases were common (77.8%) and were correlated with tumor size (>= 10 mm). The central compartment lymph node metastasis rate was 87.5%, including 26.4% of contralateral central compartment metastases. Conclusion: In PTC patients with clinical lateral lymph node metastasis, the optimal extent of lateral and central neck dissection should include levels II, III, IV and V as well as the bilateral central compartment. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | BioMed Central | - |
| dc.title | Optimal surgical extent of lateral and central neck dissection for papillary thyroid carcinoma located in one lobe with clinical lateral lymph node metastasis | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1186/1477-7819-10-221 | - |
| dc.identifier.scopusid | 2-s2.0-84867743243 | - |
| dc.identifier.wosid | 000313906700001 | - |
| dc.identifier.bibliographicCitation | World Journal of Surgical Oncology, v.10, pp 1 - 6 | - |
| dc.citation.title | World Journal of Surgical Oncology | - |
| dc.citation.volume | 10 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 6 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalResearchArea | Surgery | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Surgery | - |
| dc.subject.keywordPlus | CANCER | - |
| dc.subject.keywordPlus | COMPARTMENT | - |
| dc.subject.keywordPlus | PATTERN | - |
| dc.subject.keywordPlus | ALWAYS | - |
| dc.subject.keywordAuthor | Papillary thyroid carcinoma | - |
| dc.subject.keywordAuthor | Lateral neck dissection | - |
| dc.subject.keywordAuthor | Lymph node metastasis | - |
| dc.subject.keywordAuthor | Central neck dissection | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
